DBF4 Antikörper (AA 295-665) (Cy3)
Kurzübersicht für DBF4 Antikörper (AA 295-665) (Cy3) (ABIN7983799)
Target
Alle DBF4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 295-665
-
Verwendungszweck
- Anti-DBF4 Antibody Cy3 Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human DBF4 recombinant protein (Position:Y295-S665).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, 1-3 μg/1x106 cells
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- DBF4 (DBF4 Homolog (DBF4))
-
Andere Bezeichnung
- DBF4
-
Hintergrund
-
Background: Using both gain- and loss-of-function experiments, it was found that Xenopus Dbf4 inhibited canonical Wnt signaling. Depletion of endogenous Dbf4 did not disturb gastrulation movements or early organizer genes, but resulted in embryos with morphologically defective heart and eyes and suppressed cardiac markers. The function of Dbf4 in heart development appeared to be independent of its role in the cell cycle. Dbf4 interacted physically and functionally with Frodo, a context-dependent regulator of Wnt signaling.
Gene Full Name: DBF4-CDC7 kinase regulatory subunit
-
Gen-ID
- 10926
-
UniProt
- Q9UBU7
-
Pathways
- Mitotic G1-G1/S Phases, DNA Replication
Target
-